Age-related effects on thymic output and homeostatic T cell expansion following depletional induction in renal transplant recipients.
He XuHui-Jie LeeRobin SchmitzBrian I ShawShu LiAllan D KirkPublished in: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons (2021)
Thymic output and homeostatic mature cell proliferation both influence T cell repopulation following depletional induction, though the relative contribution of each and their association with recipient age have not been well studied. We investigated the repopulating T cell kinetics in kidney transplant recipients who underwent alemtuzumab induction followed by belatacept/rapamycin-based immunosuppression over 36-month posttransplantation. We focused specifically on the correlation between repopulating T cell subsets and the age of patients. Substantial homeostatic Ki67-expressing T cell proliferation was seen posttransplantation. A repertoire enriched for naïve T (TNaïve ) cells emerged posttransplantation. Analysis by generalized estimating equation linear models revealed a strong negative linear association between reconstituting TNaïve cells and advancing age. A relationship between age and persistence of effector memory cells was shown. We assessed thymic output and found an increase in the frequency of recent thymic emigrants (RTEs, CD4+ CD31+ ) at 12-month posttransplantation. Patients under 30 years of age showed significantly higher levels of CD4+ CD31+ cells than patients over 55 years of age pre- and posttransplantation. IL-7 and autologous mature dendritic cells (mDCs) induced CD57- cell proliferation. In contrast, mDCs, but not IL-7, induced CD57+ cell proliferation. This study establishes the relationship between age and thymic output during T cell homeostatic repopulation after alemtuzumab induction. Trial Registration: ClinicalTrials.gov - NCT00565773.
Keyphrases
- cell proliferation
- end stage renal disease
- induced apoptosis
- dendritic cells
- newly diagnosed
- ejection fraction
- chronic kidney disease
- cell cycle arrest
- cell cycle
- clinical trial
- peritoneal dialysis
- stem cells
- magnetic resonance
- oxidative stress
- computed tomography
- immune response
- cell therapy
- high glucose
- radiation therapy
- signaling pathway
- study protocol
- patient reported outcomes
- squamous cell carcinoma
- regulatory t cells
- bone marrow
- single cell
- mesenchymal stem cells
- data analysis
- atomic force microscopy